These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 482327)
41. Tilorone and related bis-basic substituted polycyclic aromatic and heteroaromatic compounds. Levin RH; Albrecht WL Prog Med Chem; 1981; 18():135-90. PubMed ID: 7045982 [No Abstract] [Full Text] [Related]
42. In vivo function tests of the effect of tilorone and niridazole on cell-mediated immunity in chickens. Donahoe JP; Giambrone J; Fletcher OJ; Kleven SH Am J Vet Res; 1977 Dec; 38(12):2013-7. PubMed ID: 23063 [TBL] [Abstract][Full Text] [Related]
43. Evaluation of the antitumor activity of rifamycin SV. Adamson RH Arch Int Pharmacodyn Ther; 1971 Jul; 192(1):61-5. PubMed ID: 5093193 [No Abstract] [Full Text] [Related]
44. Reticuloendothelial cells as the site of production of MIF induced by tilorone hydrochloride. Zschiesche W J Reticuloendothel Soc; 1979 Mar; 25(3):293-7. PubMed ID: 220421 [No Abstract] [Full Text] [Related]
45. Effect of the immunomodulator tilorone on antipyrine disposition in the rat. Svensson CK J Pharm Sci; 1986 Oct; 75(10):946-8. PubMed ID: 3795024 [TBL] [Abstract][Full Text] [Related]
46. Effect of tilorone hydrochloride on hepatic disposition of sulphobromophthalein (BSP) in the rat. Hoenig V; Werner F Xenobiotica; 1978 Mar; 8(3):157-63. PubMed ID: 654309 [TBL] [Abstract][Full Text] [Related]
47. Inhibition of deoxynucleotide-polymerizing enzyme activities of human leukemia lymphoblasts and simian sarcoma virus by tilorone and thirteen of its analogs. DiCioccio RA; Sahai Srivastava BI J Natl Cancer Inst; 1978 Mar; 60(3):533-6. PubMed ID: 203709 [TBL] [Abstract][Full Text] [Related]
48. The interaction of tilorone and RMI 9563DA with the complement system. Doherty NS Int J Immunopharmacol; 1982; 4(1):67-72. PubMed ID: 7085140 [TBL] [Abstract][Full Text] [Related]
49. Antitumor activity of 2,2-hydrazobis(3-chloro-1,4-naphthoquinone) against Walker 256(intramuscular) carcinosarcoma. Prescott B J Med Chem; 1972 Jan; 15(1):107. PubMed ID: 5007081 [No Abstract] [Full Text] [Related]
50. Comparison of the ability of small molecular interferon inducers: tilorone and acridine drugs. Gláz ET; Tálas M Arch Virol; 1975; 48(4):375-84. PubMed ID: 1200845 [TBL] [Abstract][Full Text] [Related]
51. Aryl-2-halogenoalkylamines. XXII. Derivatives of phenoxyacetic acid: synthesis and antineoplastic activities. Artico M; Ross WC Biochem Pharmacol; 1968 Jun; 17(6):873-82. PubMed ID: 5661350 [No Abstract] [Full Text] [Related]
52. Endotoxin toxicity in rats is enhanced by tilorone. Levine S; Sowinski R Proc Soc Exp Biol Med; 1976 Feb; 151(2):329-32. PubMed ID: 766017 [TBL] [Abstract][Full Text] [Related]
53. Inhibition by hydrazine sulfate and various hydrazides, of in vivo growth of Walker 256 intramuscular carcinoma, B-16 melanoma, Murphy-Sturm lymphosarcoma and L-1210 solid leukemia. Gold J Oncology; 1973; 27(1):69-80. PubMed ID: 4739164 [No Abstract] [Full Text] [Related]
54. Effect of the immunomodulator tilorone on the in vivo acetylation of procainamide in the rat. Svensson CK; Knowlton PW Pharm Res; 1989 Jun; 6(6):477-80. PubMed ID: 2474808 [TBL] [Abstract][Full Text] [Related]
55. Aryl-2-halogenoalkylamines. 23. Derivatives of oxanilic acid and salicylic acid: synthesis and antineoplastic activities. Artico M; Ross WC Biochem Pharmacol; 1968 Jun; 17(6):883-91. PubMed ID: 5661351 [No Abstract] [Full Text] [Related]
56. Effect of tilorone hydrochloride on the lymphoid and interferon responses of athymic mice. Gibson JP; Megel H; Camyre KP; Michael JG Proc Soc Exp Biol Med; 1976 Feb; 151(2):264-6. PubMed ID: 1082597 [TBL] [Abstract][Full Text] [Related]
57. Aryl-2-halogenoalkylamines. XXIV. Derivatives of o-, m- and p-aminophenol: synthesis and antineoplastic activities. Artico M; Ross WC Biochem Pharmacol; 1968 Jun; 17(6):893-8. PubMed ID: 5661352 [No Abstract] [Full Text] [Related]
58. Impaired macrophage functions as a possible basis of immunomodification by microbial agents, tilorone and dimethyldioctadecylammonium bromide. Bloksma N; de Reuver MJ; Willers JM Antonie Van Leeuwenhoek; 1983 Apr; 49(1):13-22. PubMed ID: 6351737 [TBL] [Abstract][Full Text] [Related]
59. The antipyretic effect of tilorone hydrochloride in the cat. Clark WG; Robins JA Br J Pharmacol; 1978 Feb; 62(2):281-7. PubMed ID: 304749 [TBL] [Abstract][Full Text] [Related]
60. Effect of tilorone on susceptibility of mice to primary or secondary infection with Listeria monocytogenes. Gruenewald R; Levine S Infect Immun; 1976 Jun; 13(6):1613-8. PubMed ID: 823106 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]